PD Dr. Nadja Meindl‑Beinker is a senior researcher at Heidelberg University’s Medical Faculty Mannheim in the Molecular Hepatology department. Since 2010, her work has centered on transforming growth factor‑β (TGF‑β) signaling and its complex roles in chronic liver disease and hepatocellular carcinoma . She earned her doctorate (Dr. rer. nat.) and completed postdoctoral research at Ruhr University …
Dr. Tianzuo Zhan, in addition to his translational research leadership, has received notable awards including the 2020 German Cancer Aid travel grant and the 2019 Oncology Working Group Mannheim Award. His work in GI oncology continues to garner high recognition within the department.
The Department of Medicine II has inaugurated a state-of-the-art Cell Isolation and Molecular Imaging Unit, funded by the BMBF under LiSyM and LiSyM–Cancer programs. Equipped with spatial biology tools like the GeoMx DSP, live-cell imaging systems, and AI‑based pattern recognition platforms, the facility supports both in-house projects and collaborative research across UMM.
Prof. J. Betge’s team from the department has published a comprehensive review covering diagnostics and therapy strategies for gastric cancer. This publication offers a valuable scientific update and may influence clinical decision-making and treatment guidelines umm.de.
The II. Medizinische Klinik under the leadership of Prof. Dr. Matthias Ebert has spearheaded the development of a new draft S3 guideline for colorectal cancer. Researchers and clinicians are now invited to review and provide feedback on the consultation version, which has recently been made publicly accessible. This milestone reflects the department’s active role in …
Mehr über „Draft S3 Guideline for Colorectal Cancer Led by Prof. Matthias Ebert“ Lesen